Work

Preclinical Activity of Novel BET Protein Proteolysis Targeting Chimeras (BETP-PROTACs) and Their Combination with Venetoclax or CDK4/6 Inhibitor Against Human Mantle Cell Lymphoma (MCL) Cells

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.1265.1265

Authors: Baohua Sun, Warren Fiskus, Kanak Raina, Yimin Qian, Andrew P. Crew, Dyana T. Saenz, Christopher P. Mill, Agnieszka Nowak, David N. Saenz, Craig M. Crews, Kapil N. Bhalla

Institutions: The University of Texas MD Anderson Cancer Center, Houston Methodist Research Institute, Arvinas (United States), Yale University

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3017068993

FWCI:

Cites:

Cited by:

Related to: 10